As the global HIV response faces shrinking funding, increasing pressure on civil society, and growing attacks on human rights and gender equality, UNAIDS' Eamonn Murphy has called for communities to ...

Kenya has reaffirmed its commitment to advancing the African Union's health priorities after participating in a high-level summit in Accra, Ghana, focused on accelerating action towards achieving key ...

Gilead Sciences & Merck announce investigational once-weekly oral HIV treatment regimen of islatravir and lenacapavir maintained virological suppression in adults with HIV who swi ...

A Russian missile strike has destroyed $2.6m (£1.9m) worth of HIV prevention supplies in Ukraine, according to an ...

Gilead Sciences and MSD's once-weekly oral medicine for HIV has been shown to achieve high rates of viral load suppression in ...

Gilead and Merck today (Tuesday, July 21) announced new results from the Phase 3 ISLEND-1(NCT06630286) ...

Today is Zero HIV Stigma Day. On 8 July, Dr Fred Nana Poku, Director of Technical Services at the Ghana AIDS Commission, told ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

Gilead Sciences and Merck said on Tuesday their experimental once-weekly HIV pill kept the virus suppressed in two late-stage ...

HIV treatment has progressed significantly since the 1980s. ART enables viral suppression and prevents transmission, but HIV ...

A 78-year-old grandmother develops rapid kidney failure, dramatic weight loss, and recurrent Salmonella infections after ...

The Department of Health Central Visayas (DOH-7) has assured treatment hubs and people living with HIV (PLHIV) that additional antiretroviral (ARV) medicines are expected to arrive this July following ...